Keyphrases
Actinomycin D
16%
Binding Site
100%
Cell Surface Receptor
16%
Chromatin Immunoprecipitation (ChIP)
16%
Co-transfection
16%
Coactivator
16%
Conflicting Results
16%
CREB-binding Protein
33%
Gene Expression
16%
Histone Acetylation
16%
Histone Modification
100%
Human Monocytes
50%
Luciferase Reporter Plasmid
16%
Microbial Products
100%
Mobility Shift Assay
16%
MRNA Level
16%
MRNA Transfection
16%
NF-B
100%
Overexpression
16%
P300
33%
P65 Subunit
16%
Pharmacological Inhibitors
16%
Receptor 2
100%
TLR2 Agonist
33%
TLR2 Gene
50%
TLR4 Agonist
16%
Toll-like
100%
Toll-like Receptor 2 (TLR2)
100%
Transcription Start Site
16%
Neuroscience
Actinomycin
8%
Agonist
25%
Binding Site
100%
Cell Surface Receptor
8%
Cyclic AMP Responsive Element Binding Protein Binding Protein
16%
Gene Expression
8%
Histone
8%
Histone Modification
100%
Immunoprecipitation
8%
In Vitro
8%
Luciferase
8%
Messenger RNA
25%
Plasmid
8%
Promoter Region
25%
TLR 2
100%
TLR 4
8%
Transcription Initiation Site
8%
Transfection
8%
Biochemistry, Genetics and Molecular Biology
Agonist
25%
Binding Site
100%
Cell Surface Receptor
8%
Chromatin Immunoprecipitation
8%
CREB-binding Protein
16%
Dactinomycin
8%
Gene Expression
8%
Histone
8%
Histone Modification
100%
Luciferase
8%
Messenger RNA
25%
Plasmid
8%
Promoter Region
25%
TLR2
100%
TLR4
8%
Transcription Initiation Site
8%
Transfection
8%
Medicine and Dentistry
Binding Site
100%
Cell Surface Receptor
8%
Chromatin Immunoprecipitation
8%
Cyclic AMP Responsive Element Binding Protein Binding Protein
16%
Dactinomycin
8%
Gene Expression
8%
Genetic Transfection
8%
Histone
8%
Histone Modification
100%
In Vitro
8%
Infection
8%
Luciferase
8%
Messenger RNA
25%
Plasmid
8%
Promoter Region
25%
Toll Like Receptor 2
100%
Toll Like Receptor 4
8%
Transcription Initiation Site
8%
Immunology and Microbiology
Agonist
25%
Binding Site
100%
Cell Surface
8%
Chromatin Immunoprecipitation
8%
Cyclic AMP Responsive Element Binding Protein Binding Protein
16%
Dactinomycin
8%
Gene Expression
8%
Genetic Transfection
8%
Histone
8%
Histone Modification
100%
Plasmid
8%
Promoter Region
25%
TLR2
100%
TLR4
8%
Transcription Initiation Site
8%